Simplifying Global Compliance
Device Industry Vulnerable With Pending Tax
The founding director of the FDA’s Office of Biotechnology writes in a Wall Street Journal
editorial that the pending 2.3 percent medical device tax will kill this country’s medical device industry.
The Wall Street Journal
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing